- Open Access
Correction to: CART cells are prone to Fas- and DR5-mediated cell death
Journal for ImmunoTherapy of Cancer volume 6, Article number: 92 (2018)
- The original article was published in Journal for ImmunoTherapy of Cancer 2018 6:71
After publication of this article , it was noticed that 3 authors were missed from the author list. These authors are Evripidis Lanitis, Melita Irving and George Coukos. The correct author list can be seen above and updated Competing Interests, Authors’ Contributions and Acknowledgements can be seen below.
Tschumi BO, Dumauthioz N, Marti B, Zhang L, Schneider P, Mach J-P, et al. CART cells are prone to Fas- and DR5-mediated cell death. J Immuno Cancer. 2018;6:71 https://doi.org/10.1186/s40425-018-0385-z.
We are grateful to P. Reichenbach for sharing his expertise in DNA cloning strategies. Special thanks to Prof. M. Thome for sharing her expertise in the field of T cell signalling.
All co-authors declare that they have no competing interests.
About this article
Cite this article
Tschumi, B.O., Dumauthioz, N., Marti, B. et al. Correction to: CART cells are prone to Fas- and DR5-mediated cell death. j. immunotherapy cancer 6, 92 (2018). https://doi.org/10.1186/s40425-018-0410-2